Kodiak Sciences (KOD) EBIT (2017 - 2026)

Kodiak Sciences (KOD) has 10 years of EBIT data on file, last reported at -$59.8 million in Q1 2026.

• Quarterly EBIT fell 1.19% year-over-year to -$59.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$235.1 million (down 17.62% YoY) and the FY2025 annual result came in at -$234.4 million, down 25.44% from the prior year.
• EBIT slipped to -$59.8 million in Q1 2026, from -$57.5 million in the prior quarter.
• In the past five years, EBIT ranged from a high of -$46.1 million in Q1 2024 to a low of -$95.8 million in Q1 2022.
• A 5-year average of -$64.7 million and a median of -$59.8 million in 2026 frame the typical range for EBIT.
• Annual changes were most pronounced in 2022 — EBIT tumbled 89.42% — and 2024, when it surged 43.44%.
• Tracing KOD's EBIT over 5 years: stood at -$74.1 million in 2022, then gained by 14.44% to -$63.4 million in 2023, then gained by 27.13% to -$46.2 million in 2024, then decreased by 24.41% to -$57.5 million in 2025, then decreased by 4.05% to -$59.8 million in 2026.
• The last three EBIT figures came in at -$59.8 million (Q1 2026), -$57.5 million (Q4 2025), and -$62.4 million (Q3 2025), per Business Quant data.